ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVXL Anavex Life Sciences Corporation

8.85
-0.02 (-0.23%)
Last Updated: 19:10:55
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 148.37M159.19M157.81M154.39M148.07M144.52M141.54M135.57M
Total Current Assets 148.37M159.19M157.81M154.39M148.07M144.52M141.54M135.57M
Cash and Equivalents 143.62M153.47M154.82M151.02M143.77M139.39M138.76M132.19M
Total Non-Current Assets 00000000
Total Liabilities 13.25M14.02M11.06M12.53M12.5M9.56M11.75M15.3M
Total Current Liabilities 13.25M14.02M11.06M12.53M12.5M9.56M11.75M15.3M
Total Non-Current Liabilities 00000000
Common Equity 78k80k81k82k82k84k85k85k
Retained Earnings -258.54M-271.64M-282.92M-293.07M-301.69M-312.24M-324.45M-336.07M
Year End 30 September 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 27.84M24.38M25.33M34.54M161.62M152.71M154.39M135.57M
Total Current Assets 27.79M24.32M25.33M34.54M161.62M152.71M154.39M135.57M
Cash and Equivalents 27.44M22.93M22.19M29.25M152.11M149.16M151.02M132.19M
Total Non-Current Assets 24.25M20.49M20.29M27.24M150.82M142.49M141.85M120.26M
Total Liabilities 3.58M3.89M5.04M7.31M10.8M10.21M12.53M15.3M
Total Current Liabilities 3.58M3.89M5.04M7.31M10.8M10.21M12.53M15.3M
Total Non-Current Liabilities 00000000
Total Equity 24.25M20.49M20.29M27.24M150.82M142.49M141.85M120.26M
Common Equity 43k46k53k62k76k78k82k85k
Retained Earnings -91.48M-108.93M-133.4M-159.68M-197.59M-245.56M-293.07M-336.07M

Your Recent History

Delayed Upgrade Clock